Related Experiment Video
Updated: Jun 16, 2025

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
Mechanisms and Therapeutic Strategies for Minority Cell-Induced Paclitaxel Resistance and Tumor Progression Mediated
Xueyan Feng1,2, Di Zhang1,2,3, Guoxun Wang3
1State Key Laboratory for Structural Chemistry of Unstable and Stable Species, Institute of Chemistry, CAS Research/Education Center for Excellence in Molecular Sciences, Chinese Academy of Science, Beijing, 100190, P. R. China.
Abstract:
Chemotherapy remains a prevalent strategy in cancer therapy; however, the emergence of drug resistance poses a considerable challenge to its efficacy. Most drug resistance arises from the accumulation of genetic mutations in a minority of resistant cells. The mechanisms underlying the emergence and progression of cancer resistance from these minority-resistant cells (MRCs) remain poorly understood. This study employs force-induced remnant magnetization spectroscopy (FIRMS) alongside various biological investigations to reveal the mechanical pathways for MRCs fostering drug resistance and tumor progression. The findings show that minority Paclitaxel-resistant cancer cells have enhanced mechanical properties. These cells can transmit high-intensity forces to surrounding sensitive cells (SCs) through the force transducer, Merlin. This force transmission facilitates the assimilation of surrounding SCs, subsequently strengthening the contraction and adhesion of tumor cells. This process is termed "mechano-assimilation," which accelerates the development of drug resistance and tumor progression. Interestingly, disturbances and reductions of mechano-assimilation within tumors can restore sensitivity to Paclitaxel both in vitro and in vivo. This study provides preliminary evidence highlighting the contribution of MRCs to the development of drug resistance and malignancy, mediated through mechanical interactions. It also establishes a foundation for future research focused on integrating mechanical factors into innovative cancer therapies.
Insights
Minority-resistant cancer cells enhance tumor drug resistance and progression through mechanical force transmission, a process called mechano-assimilation. Disrupting this mechanical pathway can restore Paclitaxel sensitivity.
Area of Science:
- Oncology
- Biophysics
- Cancer Biology
Background:
- Chemotherapy resistance is a major challenge in cancer treatment, often driven by genetic mutations in a small population of resistant cells.
- The mechanisms by which these minority-resistant cells (MRCs) drive resistance and tumor progression are not well understood.
- Mechanical interactions between cancer cells are increasingly recognized as important factors in tumor behavior.
Purpose of the Study:
- To investigate the mechanical pathways through which minority-resistant cancer cells (MRCs) promote drug resistance and tumor progression.
- To explore the role of mechanical force transmission in the development and maintenance of Paclitaxel resistance.
- To identify potential therapeutic strategies targeting mechanical interactions in cancer.
Main Methods:
- Utilized force-induced remnant magnetization spectroscopy (FIRMS) combined with biological assays.
- Characterized the mechanical properties of minority Paclitaxel-resistant cancer cells (MRCs) and sensitive cells (SCs).
- Investigated the role of the force transducer Merlin in force transmission and mechano-assimilation.
Main Results:
- Minority Paclitaxel-resistant cancer cells exhibit enhanced mechanical properties.
- MRCs transmit high-intensity forces to surrounding SCs via Merlin, inducing 'mechano-assimilation'.
- Mechano-assimilation accelerates drug resistance and tumor progression; its disruption restores Paclitaxel sensitivity in vitro and in vivo.
Conclusions:
- Preliminary evidence suggests MRCs contribute to drug resistance and malignancy through mechanical interactions.
- Mechano-assimilation is a novel mechanism driving cancer progression and resistance.
- Targeting mechanical factors, like mechano-assimilation, offers a promising avenue for innovative cancer therapies.
Related Concept Videos
Drugs that Stabilize Microtubules
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Treatment Resistant Cancers
The Tumor Microenvironment
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Drugs that Destabilize Microtubules

